ChemoCentryx, Inc.
![](../Images/upgraded1Icon.png)
ChemoCentryx is a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop, and commercialize orally-administered therapies.